BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5004852)

  • 1. [Trend of therapy in Pseudomonas aeruginosa infections].
    Jannuzzi C; Tassara A
    G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
    Výmola F; Jedlicková Z
    Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
    Ziółkowski G; Dudzińska G; Sakiel S
    Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
    Zavascki AP
    Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Pseudomonas aeruginosa infection.
    Eykyn SJ
    Br J Hosp Med; 1984 Feb; 31(2):136-40. PubMed ID: 6421353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
    Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
    Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 8. [O-serovars and antibiotic sensitivities in strains of Pseudomonas aeruginosa of human and animal origin].
    Zschöck M; Schliesser T
    Zentralbl Veterinarmed B; 1986 Aug; 33(6):440-6. PubMed ID: 3098000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)].
    Chernomordik AB; Panchenko MK; Bulycheva NP
    Klin Med (Mosk); 1982 Jun; 60(6):17-20. PubMed ID: 6811797
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitivity in vitro to antibiotics and chemotherapeutic agents in various hospital strains of Pseudomonas aeruginosa].
    Bertaggia A; De Negri M
    Boll Ist Sieroter Milan; 1974; 50(1):45-53. PubMed ID: 4204863
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
    Torres A; Vega J; Aguirre M; Alés JM
    Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanisms of resistance in Pseudomonas aeruginosa].
    Cercenado Mansilla E; García Garrote F
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pseudomonas aeruginosa infections].
    Tanaka E
    Naika; 1972; 29(2):286-90. PubMed ID: 4622605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effective agents against Pseudomonas pyocyanea (proceedings)].
    Meyer-Rohn J
    Z Hautkr; 1976; 51 Suppl 2():106-8. PubMed ID: 827860
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 17. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
    Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
    Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of combination of morphocycline and levomycetin on Pseudomonas aeruginosa].
    Poliak MS
    Antibiotiki; 1968 Dec; 13(12):1090-5. PubMed ID: 4976186
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ways of increasing the effectiveness of antibacterial drugs in the treatment of pseudomonas infection in burns].
    Moroz AF; Vinogradova OI; Bekbergenov BM; Brodinova NS; Antsiferova NG
    Khirurgiia (Mosk); 1976 Jun; (6):81-8. PubMed ID: 827653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.